ACM

Aisling Capital Management Portfolio holdings

AUM $360M
This Quarter Return
+28.98%
1 Year Return
+114.67%
3 Year Return
+1,171.46%
5 Year Return
+892.24%
10 Year Return
–
AUM
$243M
AUM Growth
+$243M
Cap. Flow
-$12.8M
Cap. Flow %
-5.25%
Top 10 Hldgs %
96.47%
Holding
17
New
1
Increased
–
Reduced
1
Closed
–

Top Buys

1
CMPS
Compass Pathways
CMPS
$7.14M

Top Sells

1
SYRE icon
Spyre Therapeutics
SYRE
$19.9M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
BBIO icon
1
BridgeBio Pharma
BBIO
$9.89B
$160M 65.94% 6,068,125 – –
VRNA
2
Verona Pharma
VRNA
$9.16B
$18.2M 7.49% 1,115,352 – –
SNDX icon
3
Syndax Pharmaceuticals
SNDX
$1.41B
$14.9M 6.13% 1,025,000 – –
BMEA icon
4
Biomea Fusion
BMEA
$116M
$11M 4.53% 798,757 – –
CMPS
5
Compass Pathways
CMPS
$424M
$7.14M 2.94% +964,500 New +$7.14M
GLUE icon
6
Monte Rosa Therapeutics
GLUE
$296M
$7.05M 2.91% 1,472,331 – –
OKUR
7
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$37.2M
$6.74M 2.78% 886,075 – –
NUVB icon
8
Nuvation Bio
NUVB
$1.02B
$3.4M 1.4% 2,541,009 – –
ACRS icon
9
Aclaris Therapeutics
ACRS
$209M
$2.98M 1.23% 434,455 – –
SPRB
10
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
$2.72M 1.12% 1,205,511 – –
PSTX
11
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$2.48M 1.02% 1,043,267 – –
ELEV
12
DELISTED
Elevation Oncology
ELEV
$1.88M 0.77% 2,834,910 – –
TECX
13
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
$1.56M 0.64% 1,009,779 – –
MRKR icon
14
Marker Therapeutics
MRKR
$12M
$1.43M 0.59% 314,286 – –
SYRE icon
15
Spyre Therapeutics
SYRE
$996M
$829K 0.34% 67,645 -1,623,506 -96% -$19.9M
VIRX
16
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$300K 0.12% 288,571 – –
BCEL
17
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$101K 0.04% 387,653 – –